Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil

@article{Tomljenovic2012TooFO,
  title={Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil},
  author={L. Tomljenovic and C. Shaw},
  journal={The Journal of Law, Medicine \& Ethics},
  year={2012},
  volume={40},
  pages={673 - 681}
}
There are not many public health issues where views are as extremely polarized as those concerning vaccines, and Merck's HPV vaccine Gardasil is a case in point. Ever since gaining the FDA's approval in 2006, Merck has been heavily criticized for their overly aggressive marketing strategies and lobbying campaigns aimed at promoting Gardasil as a mandatory vaccine. Subsequently, questions have been raised as to whether it was appropriate for vaccine manufacturers to partake in public health… Expand
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?
HPV vaccine: Why the rush?
  • L. V. van Bogaert
  • Medicine
  • South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
  • 2014
The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations
Lowering the Age of Consent: Pushing Back against the Anti-Vaccine Movement
  • Allison M. Whelan
  • Medicine
  • The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
  • 2016
...
1
2
3
4
...

References

SHOWING 1-10 OF 65 REFERENCES
The risks and benefits of HPV vaccination.
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
...
1
2
3
4
5
...